Eduardo Azziz‐Baumgartner

Author

Centers for Disease Control and Prevention ORCID

Also Known As

Arnold S. Monto, Azziz-Baumgartner, Eduardo, Brendan Flannery, Eduardo Azziz Baumgartner, Eduardo Azziz-Baumgartner, Eduardo Azziz-Baumgartner (13157), Eduardo Azziz‐Baumgartner, Eduardo Azziz–Baumgartner, John Barnes, Marc-Alain Widdowson (123352)

189

Publications

17.1K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention International Centre for Diarrhoeal Disease Research Institute of Epidemiology, Disease Control and Research World Health Organization Regional Office for the Americas Universidad del Valle de Guatemala

About

Eduardo Azziz‐Baumgartner is an author at Centers for Disease Control and Prevention specializing in epidemiology, public health, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	17	23	3.7K
2	Medicine	15	19	663
3	Engineering	3	3	124
4	Social Sciences	2	2	68
5	Health Sciences	1	1	23

Eduardo Azziz‐Baumgartner

106

Publications

11.1K

Citations

H-Index

Page 1

	Year	Citations
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study A. Danielle Iuliano, Katherine Roguski, Howard H. Chang, The Lancet Infectious Disease ModellingGlobal HealthEpidemiological DynamicModelling StudyComputational Epidemiology	2017	2.9K
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, JAMA	2023	792
Workgroup Report: Public Health Strategies for Reducing Aflatoxin Exposure in Developing Countries Heather Strosnider, Eduardo Azziz‐Baumgartner, Marianne Bänziger, Environmental Health Perspectives	2006	532
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway, New England Journal of Medicine	2021	519
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings Mark G. Thompson, Edward Stenehjem, Shaun J. Grannis, New England Journal of Medicine	2021	490
Case–Control Study of an Acute Aflatoxicosis Outbreak, Kenya, 2004 Eduardo Azziz‐Baumgartner, Kim A. Lindblade, Karen E. Gieseker, Environmental Health Perspectives	2005	474
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, MMWR Morbidity and Mortality Weekly Report	2022	466
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving, MMWR Morbidity and Mortality Weekly Report	2022	427
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021 Jefferson M. Jones, Mars Stone, Hasan Sulaeman, JAMA	2021	214
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 Nicola P. Klein, Melissa S. Stockwell, Maria Demarco, MMWR Morbidity and Mortality Weekly Report	2022	192

Page 1